DK33488D0 - D-gl-konjugatterapi - Google Patents
D-gl-konjugatterapiInfo
- Publication number
- DK33488D0 DK33488D0 DK033488A DK33488A DK33488D0 DK 33488 D0 DK33488 D0 DK 33488D0 DK 033488 A DK033488 A DK 033488A DK 33488 A DK33488 A DK 33488A DK 33488 D0 DK33488 D0 DK 33488D0
- Authority
- DK
- Denmark
- Prior art keywords
- conjugath
- therapy
- lysine
- antibody
- polymers
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Optics & Photonics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Polyamides (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86939386A | 1986-05-30 | 1986-05-30 | |
PCT/US1987/000197 WO1987007145A1 (en) | 1986-05-30 | 1987-02-02 | D-gl conjugate therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
DK33488A DK33488A (da) | 1988-01-25 |
DK33488D0 true DK33488D0 (da) | 1988-01-25 |
Family
ID=25353468
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK033488A DK33488D0 (da) | 1986-05-30 | 1988-01-25 | D-gl-konjugatterapi |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0272278B1 (de) |
JP (1) | JPS63503457A (de) |
AT (1) | ATE90876T1 (de) |
CA (1) | CA1309558C (de) |
DE (1) | DE3786334T2 (de) |
DK (1) | DK33488D0 (de) |
NO (1) | NO880376L (de) |
WO (1) | WO1987007145A1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6441025B2 (en) * | 1996-03-12 | 2002-08-27 | Pg-Txl Company, L.P. | Water soluble paclitaxel derivatives |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4191668A (en) * | 1977-02-03 | 1980-03-04 | Scripps Clinic And Research Foundation | Induction of immunological tolerance |
-
1986
- 1986-10-10 CA CA000520250A patent/CA1309558C/en not_active Expired - Lifetime
-
1987
- 1987-02-02 EP EP87901796A patent/EP0272278B1/de not_active Expired - Lifetime
- 1987-02-02 DE DE87901796T patent/DE3786334T2/de not_active Expired - Fee Related
- 1987-02-02 WO PCT/US1987/000197 patent/WO1987007145A1/en active IP Right Grant
- 1987-02-02 AT AT87901796T patent/ATE90876T1/de active
- 1987-02-02 JP JP62501436A patent/JPS63503457A/ja active Pending
-
1988
- 1988-01-25 DK DK033488A patent/DK33488D0/da not_active Application Discontinuation
- 1988-01-28 NO NO880376A patent/NO880376L/no unknown
Also Published As
Publication number | Publication date |
---|---|
DK33488A (da) | 1988-01-25 |
EP0272278A1 (de) | 1988-06-29 |
WO1987007145A1 (en) | 1987-12-03 |
EP0272278B1 (de) | 1993-06-23 |
JPS63503457A (ja) | 1988-12-15 |
NO880376D0 (no) | 1988-01-28 |
CA1309558C (en) | 1992-10-27 |
NO880376L (no) | 1988-01-28 |
AU7082987A (en) | 1987-12-22 |
EP0272278A4 (de) | 1990-01-08 |
AU604687B2 (en) | 1991-01-03 |
DE3786334D1 (de) | 1993-07-29 |
DE3786334T2 (de) | 1993-12-02 |
ATE90876T1 (de) | 1993-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK442688D0 (da) | Fremgangsmaade og praeparat til behandling af non-ige-medierede lidelser | |
KR930702026A (ko) | 자기항원의 경구 투여에 의한 자기면역 질병의 치료 | |
DK651689D0 (da) | Oralt autoantigenholdigt praeparat | |
PT627933E (pt) | Supressao "bystander" de doencas autoimunes | |
DK1137436T3 (da) | Stimulering af T-celler mod selvantigener under anvendelse af CTLA-4-blokeringsmidler | |
ES2144398T3 (es) | Tratamiento mejorado de enfermedades autoinmunes mediante la administracion en aerosol de autoantigenos. | |
BR9909011A (pt) | Análogo de antìgeno covalentemente reativo (craa), processos para tratar um estado de doença em um paciente inibindo-se irreversivelmente a ação de um anticorpo catalìtico, e para estimular a produção de anticorpos com atividade catalìtica, anticorpo catalìtico, processos para tratar um estado de doença em um paciente, para inibir o anticorpo catalìtico, e para imunizar passivamente um paciente, e, preparação farmacêutica para tratar uma condição patológica relacionada com a presença de anticorpos catalìticos endogenamente produzidos | |
UY23910A1 (es) | Procedimiento para la preparacion de 5- derivados sustitutivos del acido micofenolico | |
IT8683608A0 (it) | Procedimento autoallineato per la fabbricazione di celle dmos di piccole dimensioni e dispositivi mos ottenuti mediante detto procedimento. | |
ATE245030T1 (de) | Antigen-besierende heteropolymere zur behandlung von autoimmunkrankheiten mittels diesen | |
DE3781652D1 (de) | Zubereitung, geeignet fuer die behandlung von darmstoerungen. | |
DK33488A (da) | D-gl-konjugatterapi | |
ES546701A0 (es) | Procedimiento para preparar un agente terapeutico a base de celulas tumorales humanas y eventualmente, neuraminidasa. | |
NO873512L (no) | Human lav-affinitets fcepsilon-reseptor, isolering, rekombinant fremstilling og rensing av denne. | |
ES2081279T3 (es) | Utilizacion de 15-desoxiespergualina como medicamento. | |
WO1991017187A3 (en) | A 35kd tumor associated protein antigen: uses and methods of detection | |
SU1077090A1 (ru) | Способ получени вещества,специфически св зывающего раково-эмбриональный антиген опухолей толстого кишечника человека | |
Burnyasheva et al. | On the question of the treatment of urticaria | |
DE3680140D1 (de) | Behandlung von parasiterkrankungen. | |
Tkachiv | Clinical and morphological aspects of mammary gland cancer combined therapy with the inter vascular blood irradiation use.; Klyinyiko-morfologyichnyi aspekti kombyinovanogo lyikuvannya raku molochnoyi zalozi z zastosuvannyam vnutrisudinnogo opromyinyuvannya krovyi. | |
Shust | 10-year results of programmed treatment of Hodgkin's disease patients | |
IT8848016A0 (it) | Dispositivo elettro-medicale eprocedimento per la cura del dolore da nevralgie, malattie reumatiche, chirurgiche ed altre affezioni | |
RU97117537A (ru) | Мазь "черная" для лечения арахнозов, дерматомикозов и заболеваний кожи | |
UA13003A (uk) | Засіб для стимулюваhhя hавчаhhя та пам'яті | |
RU96119817A (ru) | Способ лечения дисбактериозов кишечника |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |